Targeting of aberrant mRNAs to cytoplasmic processing bodies.
about
Learning a prior on regulatory potential from eQTL dataThe frailty of adaptive hypotheses for the origins of organismal complexityThe human Pat1b protein: a novel mRNA deadenylation factor identified by a new immunoprecipitation techniqueMetal determines efficiency and substrate specificity of the nuclear NUDIX decapping proteins X29 and H29K (Nudt16)Upf1 ATPase-dependent mRNP disassembly is required for completion of nonsense- mediated mRNA decayCrystal structure of human Edc3 and its functional implicationsUpf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decayIdentification of novel filament-forming proteins in Saccharomyces cerevisiae and Drosophila melanogasterEukaryotic stress granules are cleared by autophagy and Cdc48/VCP functionThe deacetylase HDAC6 is a novel critical component of stress granules involved in the stress responseWho Regulates Whom? An Overview of RNA Granules and Viral InfectionsComposition and function of P bodies in Arabidopsis thalianaUnidirectional P-body transport during the yeast cell cycleStructural and functional insights into the human Upf1 helicase coreStructural Basis of Dcp2 Recognition and Activation by Dcp1Requirements for nuclear localization of the Lsm2-8p complex and competition between nuclear and cytoplasmic Lsm complexesSaccharomyces cerevisiae Ebs1p is a putative ortholog of human Smg7 and promotes nonsense-mediated mRNA decay.Edc3p and a glutamine/asparagine-rich domain of Lsm4p function in processing body assembly in Saccharomyces cerevisiae.Decapping activators in Saccharomyces cerevisiae act by multiple mechanisms.Global identification of new substrates for the yeast endoribonuclease, RNase mitochondrial RNA processing (MRP)The yeast Cbk1 kinase regulates mRNA localization via the mRNA-binding protein Ssd1A convergence of rRNA and mRNA quality control pathways revealed by mechanistic analysis of nonfunctional rRNA decayMicrotubule disruption stimulates P-body formationStress-dependent relocalization of translationally primed mRNPs to cytoplasmic granules that are kinetically and spatially distinct from P-bodiesP bodies promote stress granule assembly in Saccharomyces cerevisiae.mRNA localization to P-bodies in yeast is bi-phasic with many mRNAs captured in a late Bfr1p-dependent wave.Yeast Upf1 CH domain interacts with Rps26 of the 40S ribosomal subunit.Upf1 potentially serves as a RING-related E3 ubiquitin ligase via its association with Upf3 in yeastNucleocytoplasmic shuttling of Ssd1 defines the destiny of its bound mRNAsDiverse Strategies Used by Picornaviruses to Escape Host RNA Decay PathwaysInteractions between the HIV-1 Unspliced mRNA and Host mRNA Decay MachineriesTTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elementsFunctions of the nonsense-mediated mRNA decay pathway in Drosophila developmentmRNA decay proteins are targeted to poly(A)+ RNA and dsRNA-containing cytoplasmic foci that resemble P-bodies in Entamoeba histolyticaDeadenylation is prerequisite for P-body formation and mRNA decay in mammalian cellsCalcineurin Targets Involved in Stress Survival and Fungal VirulenceHow and where are nonsense mRNAs degraded in mammalian cells?Eukaryotic stress granules: the ins and outs of translationPoliovirus-mediated disruption of cytoplasmic processing bodiesThe dynamics of mammalian P body transport, assembly, and disassembly in vivo.
P2860
Q21145013-8E506EFB-328C-49B5-80AB-B7155B9BF79FQ22066346-4F88F9FE-22CB-4529-9B6B-53235AFE7E78Q24300195-672EB0FB-6E17-4FDE-9136-15BB6E7FDAABQ24310271-6266491F-ED0A-44BE-9C66-E3DB90EA9F72Q24314490-7E0680DA-95AC-463D-888A-E7197B679878Q24320305-CB23937B-6119-43EC-ACF6-9B45B08E7E3CQ24323275-1B96567D-EE90-49D3-BE1D-CFB49323396BQ24627262-91D239C3-F685-4D68-AE50-5908799D8A0FQ24629019-669D4493-ACDB-4EAA-9063-BC3F510E6045Q24680794-9A03DC77-6735-400F-AE9C-72ECBB21C94CQ26700102-BF2A6D01-C182-40AC-9EC8-054002460778Q26864862-CC0D1601-05C6-4D52-864D-6A609B56470AQ27324125-E328431B-80CB-49AB-A514-9941B261B4DDQ27640680-3D15AADB-D97A-45AD-8134-3A4C42966DFCQ27649872-4AD0A418-03E4-4F2D-9416-EE00ED52C7ECQ27930154-7ED4CFB4-FDAA-45AE-8C1A-2513CF1ED116Q27930308-39AC58EC-0B6C-49A8-9E06-53FC0ADCB058Q27930894-3A2D7AF1-49FE-4367-8B3B-95B6B4E19011Q27931642-27303C83-9588-4C5B-BED6-01409B7F9491Q27932758-9C2705E9-C5D7-4225-992C-9B67EC348253Q27933806-B663598C-3981-42C7-BFAA-EB3FF21013B7Q27934461-8917AC6A-5D7D-463B-978D-8B1ADED60B8DQ27935231-D65CE741-9A9B-49FF-928B-55E7E231AE92Q27935514-F9BE1D0B-12A7-4800-B83F-350FD2BB138EQ27937387-1990FA89-BCC5-4C1B-9360-548855439BA0Q27937961-4132B067-585D-45C6-9A63-A4C31B34D87CQ27938110-530BE178-3D53-40DC-8A93-83F9A50B78EBQ27938201-0B31F385-450D-40E1-8F2F-4F65D42E107EQ27938529-79D02F95-1E5C-45FD-87C3-D3B537A2F8F5Q28077216-2E294DDF-15CB-447D-9F10-3EFCA8E5F111Q28078564-6671222C-B36F-4BDC-A03D-3396E51B1BF1Q28117692-F99CFB50-8F5E-4D5F-B6ED-045AA751B5F1Q28469087-D2396216-0998-461D-86BF-4A91AC910B9CQ28483974-6CC40F41-9D2A-4B6D-943A-ABC4E047D2B7Q28508125-71BF9FC0-49BA-409F-AF0A-0F9D74EBFDCEQ28553977-317D9791-7867-4609-BE76-EAECF6F6F8A9Q28636081-E7201FE7-DF2E-47B8-BEC0-69223082D333Q29619569-A1D04B25-B477-43F7-8FEE-05E3AE0D461AQ30155985-CA40B1DD-BA1E-4F73-B7CF-8C2C9AA8AD69Q30483777-D1F6FDE4-145B-44EF-929C-8534BB846B5E
P2860
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
@ast
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
@en
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
@nl
type
label
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
@ast
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
@en
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
@nl
prefLabel
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
@ast
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
@en
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
@nl
P2860
P3181
P1433
P1476
Targeting of aberrant mRNAs to cytoplasmic processing bodies.
@en
P2093
Roy Parker
Ujwal Sheth
P2860
P304
P3181
P356
10.1016/J.CELL.2006.04.037
P407
P577
2006-06-16T00:00:00Z